News

January 7, 2019

Circulating Tumor Cell Numbers May Help Decide Best Therapy for Metastatic Breast Cancer, Phase 3 Trial Shows

News

The number of circulating tumor cells (CTCs) could help doctors choose between hormone therapy or chemotherapy for the first-line treatment of metastatic breast cancer patients whose tumors produce estrogen receptor ... Read more

January 4, 2019

Phase 3 Trial of Sacituzumab Govitecan Recruiting Triple-negative Breast Cancer Patients

News

A Phase 3 trial is recruiting participants to examine the effects of sacituzumab govitecan in patients with metastatic triple-negative breast cancer (TNBC) who failed to respond, or relapsed after at least two ... Read more

January 2, 2019

Study Reveals a Weakness of Breast Cancer Bone Metastasis

News

A new study analyzing the cross-talk between bone cells and cancer cells in metastatic breast cancer models may have uncovered a weakness that can be exploited to stop breast cancer ... Read more

December 17, 2018

Enrollment Complete in Phase 2 Trial of NeuVax-Herceptin for HER2-Positive, High-Risk Breast Cancer

News

The investigator-sponsored trial studying a combination of NeuVax (nelipepimut-S, NPS) and Herceptin (trastuzumab) as a maintenance treatment for HER2-positive breast cancer at high risk of recurrence has completed patient enrollment, Sellas Life Sciences, ... Read more

December 14, 2018

Couple Share $1.8 Million to Test More Precise Image-guided Breast Radiation Therapy

News

A new strategy for delivering a higher dose of radiotherapy with increased precision to breast tumors — while sparing healthy tissue — has been awarded more than $1.8 million from ... Read more

December 10, 2018

Phase 1/2 Trial Testing Combo of Bria-IMT and Immune Checkpoint Inhibitors Begins Dosing Breast Cancer Patients

News

BriaCell Therapeutics has started patient dosing in a Phase 1/2a clinical trial testing its immunotherapy candidate Bria-IMT — used in combination with the immune checkpoint inhibitors Keytruda (pembrolizumab) or Yervoy (ipilimumab) — ... Read more

December 7, 2018

J. Lohr Vineyards Marks 10 Years of Supporting the National Breast Cancer Foundation

News

J. Lohr Vineyards & Wines’ 10-year partnership with the National Breast Cancer Foundation (NBCF) has helped to provide more than 6,500 mammograms for women in need and is still going ... Read more

December 3, 2018

Planned Phase 2 Trial to Test Vaccine in Triple-negative Breast Cancer Patients, Generex Says

News

Generex Biotechnology has entered into an agreement with the NSABP Foundation to manage a possible Phase 2 clinical trial testing an anti-cancer vaccine in patients with metastatic triple negative breast cancer. ... Read more

November 30, 2018

2 Trials, Now Enrolling, Aimed at Improving Breast Cancer Prevention, Diagnosis, and Treatment

News

The University of Hawaiʻi Cancer Center is enrolling participants in two clinical trials to test new ways of preventing and diagnosing breast cancer, as well as improving current treatments. “These trials are very ... Read more